.jpg)
Daniel G. Anderson is the Joseph R. Mares [1924] Professor of Chemical Engineering, and a core member of the Institute for Medical Engineering and Science, and the Koch Institute for Integrative Cancer Research. He is a leading researcher in the fields of nanotherapeutics and biomaterials. Prof. Anderson’s work has led to advances in a range of areas, including medical devices, cell therapy, drug delivery, gene therapy and material science, and has resulted in the publication of more than 550 papers, patents, and patent applications. These advances have led products that have been commercialized or are in clinical development, as well as to the foundation of companies in the pharmaceutical, biotechnology, and consumer products space. He has founded a number of companies, including Living Proof, Olivo Labs, Crispr Therapeutics (CRSP), Sigilon Therapeutics, Verseau Therapeutics, oRNA, and VasoRx, and Soufflé Therapeutics. He is a member of National Academy of Medicine, the Harvard-MIT Division of Health Science and Technology, a Fellow of the National Academy of Inventors, and is an affiliate of the Broad and Ragon Institutes.
Daniel G. Anderson is the Joseph R. Mares [1924] Professor of Chemical Engineering, and a core member of the Institute for Medical Engineering and Science, and the Koch Institute for Integrative Cancer Research. He is a leading researcher in the fields of nanotherapeutics and biomaterials. Prof. Anderson’s work has led to advances in a range of areas, including medical devices, cell therapy, drug delivery, gene therapy and material science, and has resulted in the publication of more than 550 papers, patents, and patent applications. These advances have led products that have been commercialized or are in clinical development, as well as to the foundation of companies in the pharmaceutical, biotechnology, and consumer products space. He has founded a number of companies, including Living Proof, Olivo Labs, Crispr Therapeutics (CRSP), Sigilon Therapeutics, Verseau Therapeutics, oRNA, and VasoRx, and Soufflé Therapeutics. He is a member of National Academy of Medicine, the Harvard-MIT Division of Health Science and Technology, a Fellow of the National Academy of Inventors, and is an affiliate of the Broad and Ragon Institutes.
Daniel G. Anderson is the Joseph R. Mares [1924] Professor of Chemical Engineering, and a core member of the Institute for Medical Engineering and Science, and the Koch Institute for Integrative Cancer Research. He is a leading researcher in the fields of nanotherapeutics and biomaterials. Prof. Anderson’s work has led to advances in a range of areas, including medical devices, cell therapy, drug delivery, gene therapy and material science, and has resulted in the publication of more than 550 papers, patents, and patent applications. These advances have led products that have been commercialized or are in clinical development, as well as to the foundation of companies in the pharmaceutical, biotechnology, and consumer products space. He has founded a number of companies, including Living Proof, Olivo Labs, Crispr Therapeutics (CRSP), Sigilon Therapeutics, Verseau Therapeutics, oRNA, and VasoRx, and Soufflé Therapeutics. He is a member of National Academy of Medicine, the Harvard-MIT Division of Health Science and Technology, a Fellow of the National Academy of Inventors, and is an affiliate of the Broad and Ragon Institutes.